one million fraud involving fake HIV medicines SIDN, the Federal Criminal Police Office (BKA) and several prosecutors on the track. According to investigations of Radio station NDR Info ", the investigators determined against various pharmaceutical wholesalers. You are provided for patients in Africa, subsidized products repackaged in large quantities, have illegally taken to Germany and sold here with an extremely high profits. The financial loss is estimated at least tens of millions.
According to information of the NDR, the HIV medications as part of the so-called bulk - so loose tablets in boxes and bags - illegally from South Africa to Belgium and Switzerland imported to Germany. Here are the defendants have sold the drugs with substantial gains, the Prosecutor Flensburg. According to information of the transmitter alone, sales of an accused at around six million euros.
AOK Niedersachsen estimates that the financial loss but for health insurance is at least double-digit million range, because the perpetrators are said to have settled the counterfeit products at regular prices at the tills. "The drugs were provided by relief agencies for the treatment of HIV patients in South Africa. The wholesalers have brought the products to Germany, although they were not allowed here," said the speaker of the Lower Saxony AOK, Oliver gable NDR
Gerd Glaeske, pharmaceutical expert the University of Bremen, condemned in the strongest terms the possible fraud. "This is not only enrich wholesaler with criminal energy, but here people are harmed, where these drugs are withheld, and that is particularly reprehensible."
From today's effectiveness of the drugs was not affected. However, it is still investigating whether the drugs have taken for example by interrupting the cold chain damage. You may also see the expiration date was exceeded. Many pharmaceutical companies provide developing countries their HIV drugs, usually given to relief organizations, affordable available. So they do and a. prevent counterfeiters circumvent the patent protection.
0 comments:
Post a Comment